Meysam Yazdankhah

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD”.

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD

Nature Communications(2024)10.1038/s41467-024-50500-z

N/A

0.692DataRank · unranked

31 citations

Ruchi Sharma, Sridhar Bammidi, Victoria Koontz, Mihir Nemani, Meysam Yazdankhah +29 more

βA1-crystallin regulates glucose metabolism and mitochondrial function in mouse retinal astrocytes by modulating PTP1B activity

Communications Biology(2021)10.1038/s42003-021-01763-5

N/A

0DataRank · unranked

18 citations

Haitao Liu, Meysam Yazdankhah, Nadezda A. Stepicheva, Peng Shang, Tanuja Vaidya +24 more

Mitophagy in Astrocytes Is Required for the Health of Optic Nerve

Cells(2023)10.3390/cells12202496

N/A

0DataRank · unranked

8 citations

Sayan Ghosh, Haitao Liu, Stacey Hose, J. Samuel Zigler, Debasish Sinha +1 more

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in atrophic AMD

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.08.552343

N/A

0DataRank · unranked

3 citations

Ruchi Sharma, Sridhar Bammidi, Victoria Koontz, Mihir Nemani, Meysam Yazdankhah +21 more